Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0M3BB
|
||||
Former ID |
DIB004227
|
||||
Drug Name |
Synthetic hypericin
|
||||
Synonyms |
Hypericin; VIMRxyn; Synthetic hypericin, Nexell
|
||||
Indication | Viral infections [ICD9: 054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053; ICD10:B01, B02, A60, B00, B27, G05.1, P35.2] | Phase 3 | [525201] | ||
Company |
Nexell Therapeutics Inc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c12C(=O)c3c4c5c1c(c1c6c(C(=O)c7c(c56)c(c4c(cc3O)C)c(cc7<br />O)C)c(cc1O)O)c(cc2O)O
|
||||
CAS Number |
CAS 548-04-9
|
||||
Target and Pathway | |||||
Target(s) | Protein kinase C | Target Info | Inhibitor | [527958] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.